Amidapsone

This classification denotes an antiviral agent and antimicrobial with the molecular formula C13H13N3O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8N5BE1I42E, chemically known as urea, (p-sulfanilylphenyl)- (8ci) but generally known as amidapsone, which bears US NIH Compound Identifier 66267. European Medicines Agency schedules Amidapsone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05426MIG. The term AMIDAPSONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 27, No. 10 1973, List 13). AMIDAPSONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amidapsone under HS 29309085 and SITC 51549. As of Q4 2014, AMIDAPSONE remains the US FDA Preferred Term for this commodity. Amidapsone bears US NLM identifiers UMLS ID C2346737 and NCI Concept Code C73196. SMILES: S(=O)(=O)(C1CCC(NC(=O)N)CC1)C1CCC(N)CC1.